Huai Qi Huang ameliorates proteinuria and hematuria in mild IgA nephropathy patients: A prospective randomized controlled study

Journal of the Formosan Medical Association

Volumn 112, Issue 12, 2013, Pages 766-772

  Li, Lei Ting ^a   Shi, Ming Yang ^a   Wei, Shi Yao ^a   Li, Tong ^a   Li, Bing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Hematuria; Huai Qi Huang granule; Immunoglobulin A nephropathy; Proteinuria

Indexed keywords

HERBACEOUS AGENT; HUAI QI HUANG; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PATHOLOGY; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; COMPLICATION; GLOMERULONEPHRITIS, IGA; LYCIUM; PHYTOTHERAPY; POLYGONATUM; PROSPECTIVE STUDY; TRAMETES; YOUNG ADULT;

ADULT; DRUGS, CHINESE HERBAL; FEMALE; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; LYCIUM; MALE; PHYTOTHERAPY; POLYGONATUM; PROSPECTIVE STUDIES; PROTEINURIA; TRAMETES; YOUNG ADULT;

EID: 84890153008     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2013.10.019     Document Type: Article

References (34)

1. Le W., Liang S., Hu Y., Deng K., Bao H., Zeng C., et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 2012, 27:1479-1485.
2. Wyatt R.J., Julian B.A. IgA nephropathy. N Engl J Med 2013, 368:2402-2414.
3. Coppo R., D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005, 18:503-512.
4. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004, 24:179-196.
5. Reich H.N., Troyanov S., Scholey J.W., Cattran D.C. Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007, 18:3177-3183.
6. Chang F.C., Chou Y.H., Chen Y.T., Lin S.L. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. J Formos Med Assoc 2012, 111:589-598.
7. Wang W.J., Wu H.S., Chu T.S. Anti-neutrophil cytoplasmic antibody-associated Pauci-immune crescentic glomerulonephritis complicating Sjogren's syndrome. J Formos Med Assoc 2011, 110:473-477.
8. Hung P.H., Chiu Y.L., Lin W.C., Chiang W.C., Chen Y.M., Lin S.L., et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc 2006, 105:804-812.
9. Yang H.Y., Wang J.D., Lo T.C., Chen P.C. Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists. J Formos Med Assoc 2011, 110:161-168.
10. Xiong G., Chen X., Li X., Fang D., Zhang L., Yang L., et al. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients. J Formos Med Assoc 2013, [Epub ahead of print]. 10.1016/j.jfma.2013.04.001.
11. Moreno J.A., Martin-Cleary C., Gutiérrez E., Rubio-Navarro A., Ortiz A., Praga M., et al. Haematuria: the forgotten CKD factor?. Nephrol Dial Transplant 2012, 27:28-34.
12. Vivante A., Calderon-Margalit R., Skorecki K. Hematuria and risk for end-stage kidney disease. Curr Opin Nephrol Hypertens 2013; Feb 27, [Epub ahead of print].
13. Lv J., Zhang H., Chen Y., Li G., Jiang L., Singh A.K., et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 2009, 53:26-32.
14. Manno C., Torres D.D., Rossini M., Pesce F., Schena F.P. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant 2009, 24:3694-3701.
15. Tang S., Leung J.C., Chan L.Y., Lui Y.H., Tang C.S., Kan C.H., et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 2005, 68:802-812.
16. Tang S.C., Tang A.W., Wong S.S., Leung J.C., Ho Y.W., Lai K.N. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int 2010, 77:543-549.
17. Ji D.L., Mai D.H. Effect of Huaier granule on immunity and quality of life in patients with gastric cancer undergoing postoperative concurrent radiochemotherapy. China Cancer 2010, 19:73-76.
18. Zhang N., Kong X., Yan S., Yuan C., Yang Q. Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci 2010, 101:2375-2383.
19. Zhu C., Huang S., Ding G., Yuan Y., Chen Q., Pan X., et al. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats. Pediatr Nephrol 2011, 26:905-913.
20. Sun Y., Sun T., Wang F., Zhang J., Li C., Chen X., et al. A polysaccharide from the fungi of Huaier exhibits anti-tumor potential and immunomodulatory effects. Carbohydr Polym 2013, 92:577-582.
21. Zhang A.Q., Fu S.L., Ji L.L. Effect of Huai Qi Huang on immunofunction of children with recurrent respiratory infection. J Harbin Med Univ 2011, 45:269-271.
22. Zhang B., Ni N., Wu Y.B. Effect of Huaiqihuang particles on serum TNF-α, IL-18 and IL-10 in children with primary nephrotic syndrome. Chinese J Pract Pediatrics 2010, 25:33-36.
23. Arrizabalaga P., Solé M., Quinto I.L., Ascaso C. Intercellular adhesion molecule-1 mediated interactions and leucocyte infiltration in IgA nephropathy. Nephrol Dial Transplant 1997, 12:2258-2262.
24. Yu H.H., Chiang B.L., Yang Y.H. Altered glycosylation of circulatory IgA1 involved in Henoch-Schonlein purpura and IgA nephropathy. J Formos Med Assoc 2012, 111:121-122.
25. Chan L.Y., Leung J.C., Tsang A.W., Tang S.C., Lai K.N. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int 2005, 67:602-612.
26. Chintalacharuvu S.R., Yamashita M., Bagheri N., Blanchard T.G., Nedrud J.G., Lamm M.E., et al. T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy. Clin Exp Immunol 2008, 153:456-462.
27. Lai K.N., Leung J.C., Chan L.Y., Saleem M.A., Mathieson P.W., Lai F.M., et al. Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 2008, 294:F945-F955.
28. Appel G.B., Waldman M. The IgA nephropathy treatment dilemma. Kidney Int 2006, 69:1939-1944.
29. Barratt J., Feehally J. Treatment of IgA nephropathy. Kidney Int 2006, 69:1934-1938.
30. Coppo R., Feehally J., Glassock R.J. IgA nephropathy at two score and one. Kidney Int 2010, 77:181-186.
31. Ren J., Zheng C., Feng G., Liang H., Xia X., Fang J., et al. Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 2009, 29:198-201.
32. Wang X., Zhang N., Huo Q., Yang Q. Anti-angiogenic and antitumor activities of Huaier aqueous extract. Oncol Rep 2012, 28:1167-1175.
33. Shen P., He L., Li Y., Wang Y., Chan M. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract 2007, 106:c157-c161.
34. Yamagata K., Yamagata Y., Kobayashi M., Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996, 45:281-288.